| Title： | Chinese expert consensus on clinical practice of adult central neuropsychiatric lupus (2024 edition) |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Clinicians, clinical pharmacists, and nurses who care for adult patients |
| Evidence classification method： | The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system would be used to grade the evidence and recommendations. For some clinical problems without evidence support, based on the clinical experience of experts, the recommendations would be formed based on expert consensus，namely Good Practice Statement (GPS). |
| Development unit： | National Clinical Research Center for Skin and Immune Diseases (NCRC-DID), Chinese Rheumatology Association, Key Laboratory of Rheumatism and Immunology of Ministry of Education, Chinese SLE Treatment and Research group(CSTAR) |
| Registration time: | 2024-03-12 |
| Registration number： | PREPARE-2024CN281 |
| Purpose of the guideline: | This consensus is formulated in order to further improve the level of diagnosis and treatment of adult central neuropsychiatric lupus in China, and promote the standardization of clinical practice in rheumatology and immunology. The development of high-quality expert consensus on clinical practice can not only improve the overall level of disease diagnosis and treatment, reduce the burden of patients and families, but also help to reduce social medical costs and promote the rational use of medical resources. |
